a r t i c l e s
To avoid unwanted checkpoint activation by natural chromosome ends, cells have evolved telomeres. Human telomeres are composed of double-stranded 5′-TTAGGG-3′ repeats and a single-stranded G-rich 3′ overhang, which are covered and protected by shelterin 1 . Among the six shelterin components, TRF2 and POT1 have predominantly been implicated in chromosome end protection by preventing ATMand ATR-dependent checkpoint activation [2] [3] [4] [5] . Upon disruption of TRF2 or POT1, telomeres are recognized as sites of DNA damage, resulting in phosphorylation of histone H2AX (γ-H2AX) within the telomeric and subtelomeric chromatin and association of 53BP1 with the chromosome ends. The colocalization of DNA damage response factors and chromosome ends can be visualized as telomere dysfunction-induced foci (TIF) 6 . TIF have also been intimately linked to replicative senescence 7 and shown to occur spontaneously in cancer cell lines 8 .
Cells arrested in mitosis are known to either die during mitotic arrest, or skip cytokinesis and 'slip' into the subsequent G1 phase of the cell cycle 9 . Mitotic slippage occurs through the degradation of cyclin B1 in the presence of the active spindle assembly checkpoint (SAC) 10 . Cells that exit from prolonged mitotic arrest or progress through mitotic slippage have various fates, including apoptosis or p53-dependent cell-cycle arrest 9, 11 . In both normal and cancer cells, cell death during mitotic arrest, or apoptosis or senescence after escape from prolonged mitotic arrest, are crucial for preventing chromosome instability. A failure to remove cells from the cycling population following prolonged mitotic arrest may allow cells to continue propagating with an abnormal number of chromosomes [12] [13] [14] . However, despite intense research, the molecular mechanisms that trigger growth arrest or death in mitotically arrested cell cultures have not yet been identified.
We set out to explore putative telomeric functions for cohesin and found that mitotic arrest per se induces telomere deprotection in primary and transformed human cells. Telomere deprotection during mitotic arrest associated with loss of the telomeric 3′ overhangs led to ATM activation and was ATM dependent. TRF2 was dissociated from telomeres during prolonged mitotic arrest, providing the molecular basis for overhang loss and ATM activation, which was validated by the finding that TRF2 overexpression protected telomeres from the damage machinery during mitotic arrest.
Inhibition of Aurora B kinase suppressed the telomere deprotection phenotype but did so independently of the involvement of the SAC. Cells suffering from mitotic telomere deprotection underwent p53-dependent cell-cycle arrest in the following G1 phase after mitotic release, whereas cells lacking p53 function continued to cycle and became aneuploid. Our findings provide a molecular mechanism explaining the induction of DNA damage signaling, cell-cycle arrest or apoptosis following prolonged mitotic arrest, and they explain the mechanism of action of therapeutic drugs such as Taxol, vinblastine and Velcade, which all inhibit mitotic progression. We propose that telomeric destabilization during mitotic arrest induces DNA damage signaling and potentially serves as a mitotic-duration checkpoint that is responsible for eliminating cells that fail to progress through mitosis properly.
RESULTS

Prolonged mitotic arrest induces telomeric DNA damage foci
Cohesin, composed of the core subunits SMC1, SMC3, RAD21 (the human ortholog of budding yeast SCC1) and SCC3, was originally found to prevent premature sister chromosome separation during mitosis 15, 16 and has also been shown to be involved in checkpoint activation, damage repair and recombination [17] [18] [19] [20] . Thus, we asked a r t i c l e s whether cohesin functions were involved in telomeric protection. RAD21 was knocked down in HeLa1.2.11 cells (Fig. 1a, top) , resulting in premature sister chromatid separation and a mitotic arrest phenotype 21 . Mitotic cells were spread by cytocentrifugation and stained for γ-H2AX immunofluorescence and telomere fluorescent in situ hybridization (FISH) to visualize potential TIF on prometaphaselike nuclei (meta-TIF) 8 . Multiple TIF were observed when RAD21 was suppressed (Fig. 1b, top right) , in contrast to mock-treated and non-silencing short interfering RNA (siRNA)-treated cells (Fig. 1b,  top left) . Quantitation of the TIF revealed a four-fold increase in damage signals on all chromosome ends and a nine-fold increase at the telomeres of mitotic nuclei with prematurely separated sister chromatids, which are about 40% of the population and indicate efficient cohesin knockdown (Fig. 1c, left) . To distinguish which function of cohesin is involved in this phenotype, we focused on sororin and shugoshin. Sororin is required for sister chromatid cohesion and for doublestrand break (DSB) repair, but unlike cohesin, sororin is dispensable for checkpoint activation 20, 22 . Shugoshin is required for maintenance of cohesin at centromeres in mitosis, but is dispensable for checkpoint and repair functions 22 . Sororin and shugoshin were both efficiently suppressed by siRNA targeting (Fig. 1a, bottom) . Both knockdowns induced premature sister chromatid separation and a ten-fold increase in meta-TIF (Fig. 1b, bottom and Fig. 1c, middle) . This suggested that either cohesin, sororin and shugoshin are directly involved in telomere protection, or that mitotic arrest induced by the knockdowns indirectly caused telomere deprotection. We therefore treated HeLa1.2.11 cells with the microtubule-destabilizing drug colcemid, which also arrests cells in mitosis. This treatment led to a similar increase in meta-TIF formation, as observed upon the suppression of cohesin, sororin and shugoshin (Fig. 1c, right and Supplementary Fig. 1a ), suggesting that it was the prolonged mitotic arrest that was the major cause of the meta-TIF phenotype.
Primary cells also show telomere deprotection following prolonged arrest in M phase. Colcemid addition to primary human diploid lung fibroblasts (IMR90) led to the formation of multiple TIF (Fig. 1d) in a time-dependent manner ( Fig. 1e and Supplementary Fig. 2a) ; in extreme cases, this led to the deprotection of almost all telomeres (Supplementary Fig. 1b) . γ-H2AX did not accumulate at nontelomeric sites ( Fig. 1e and Supplementary Fig. 2a) . Human mammary epithelial cells showed the same telomere deprotection phenotype (Supplementary Fig. 2b) .
To examine meta-TIF formation dynamics, IMR90 cells were synchronized at the G1-S boundary and cell-cycle progression and mitosis entry was determined by histone H3 Ser10 phosphorylation (H3S10P) and DNA content (Supplementary Fig. 2c ). Cells entered mitosis 8-12 h post release and reentered G1 by 14 h. Colcemid was npg a r t i c l e s added at the 6 h time point, and meta-TIF formation in mitotic nuclei was determined at 10, 16 and 30 h (Fig. 2a) . At 10 h post release, only background levels of telomeric and non-telomeric γ-H2AX foci were observed, suggesting that perturbation of microtubules during G2 has no effect on telomeres ( Fig. 3 ). This again indicates that deprotected telomeres accumulate during mitotic arrest but not in G2. Irradiation of mitotic cells at 10 h post release induced nontelomeric γ-H2AX foci, excluding the possibility that only the telomeric region is competent for γ-H2AX foci formation during mitosis ( Fig. 2b, 1 Gy IR, and Supplementary Fig. 3 ).
Mitotic inhibitors such as vinblastine, Taxol and Velcade are frequently used in cancer therapy. Vinblastine depolymerizes microtubules, whereas Taxol stabilizes them 23 , and the proteasome inhibitor Velcade blocks proteolysis of anaphase-promoting complex (APC) substrates, leading to arrest at the metaphase-anaphase transition 24 . Dimethylenastron is a kinesin Eg5 inhibitor that blocks centrosome segregation and causes monopolar kinetochore formation 25 . Because Velcade appears to affect G2 progression as well, we added Velcade at the 8-h time point, when cells had started entering M phase (Fig. 2a) . All drugs caused meta-TIF formation at 16 and 30 h, except for Velcade, which led to a poor mitotic index 30 h post release, probably because of the side effects of proteasome inhibition ( Fig. 2b and Supplementary Fig. 3 ).
We suggest that the induction of the meta-TIF phenotype is independent of the pathways that lead to mitotic arrest, and that it is the length of time spent in mitosis that causes telomere deprotection.
Mitotic arrest causes 3′ overhang loss and ATM activation
To study whether the 3′ overhang was affected during prolonged mitosis, we colcemid-treated synchronized IMR90 cells and IMR90 cells expressing papilloma virus serotype 16 (HPV16) E6 and E7 proteins (IMR90 E6E7). Cells were harvested 0, 10 and 24 h post release, either by collection of the total sample or through mitotic shake-off ( Fig. 3a) , and the overhang status was analyzed 26 . We observed an approximate 50% reduction of overhang signal at the 24-h time point (Fig. 3b) , probably in the mitotic fraction of cells, as the samples collected by mitotic shake-off showed an even more extensive loss of the 3′-overhang signal (Fig. 3b) . Exonuclease I treatment confirmed that the telomeric signal from native hybridization stemmed from the 3′ overhangs, and no detectable change in the length of doublestranded telomeres was observed ( Supplementary Fig. 4) .
To demonstrate that telomeric ends, but not internal telomeric sequences, are required for the mitotic TIF phenotype, we suppressed TRF2 in IMR90 E6E7 cells (Fig. 3c) . Meta-TIF analysis following colcemid exposure demonstrated that the internal telomeric sequences caused by TRF2 knockdown-induced telomere fusions do not induce a DNA damage signal (Fig. 3d,e) . This supports the hypothesis that telomeric ends, but not internal telomeric sequences or subtelomeric regions, are involved in the meta-TIF phenotype.
To study the checkpoint response during mitotic arrest, synchronized IMR90 cells with or without colcemid exposure were analyzed by western blotting. In the presence of colcemid, H3S10P accumulated (Fig. 3f) , indicating an accumulation of cells in mitosis. Elevation of γ-H2AX expression was observed after 16 and 30 h, similarly to ATM autophosphorylation (ATM-Ser1981P) (Fig. 3f) . Exposure of unsynchronized IMR90 cells to colcemid confirmed that ATM activation was concomitant with the induction of telomere deprotection and not simply a side effect of synchronization (data not shown). Meta-TIF analysis of SV40-immortalized ATM-deficient fibroblasts (A-T SV40) suggested that ATM is required for telomeric γ-H2AX focus formation during mitotic arrest ( Fig. 4a; top) . Quantification of γ-H2AX foci indicated that the A-T SV40 cells suffered from a greater number of non-telomeric γ-H2AX foci compared to IMR90 cells ( Fig. 4b; non-TEL), but no increase in TIF formation was observed after 24 h of colcemid exposure ( Fig. 4b; TEL) , despite equal efficiency of the mitotic arrest (Supplementary Fig. 5a ). Moreover, an immortalized A-T fibroblast cell line expressing HPV 16 E6 and E7 (A-T E6E7) failed to increase telomeric γ-H2AX foci after 24 h of colcemid treatment (Fig. 4b) , and short hairpin (shRNA)-mediated suppression of ATM in HeLa1.2.11 cells reduced the number of telomeric γ-H2AX foci after 24 h of colcemid exposure (Fig. 4c,d ).
An immortalized HPV16 E6 and E7 expressing a Seckel-syndrome fibroblast cell line with a hypomorphic mutation in the ATR pathway (Seckel E6E7) showed an acute increase of telomeric γ-H2AX foci after prolonged mitotic arrest (Fig. 4a, bottom) , comparable to what was found for the IMR90 cells (Fig. 4b) . We therefore concluded that ATM, but not ATR, activation during mitotic arrest is upstream of H2AX phosphorylation at telomeric ends. However, owing to the hypomorphic nature of the mutation in the Seckel cells, we cannot completely exclude a partial contribution by the ATR pathway. npg a r t i c l e s whether TRF2 was still localized to telomeres after prolonged mitotic arrest. Synchronized IMR90 cells were analyzed by chromatin immunoprecipitation (ChIP) with antibodies to TRF1, TRF2 and histone H3. Histone H3 was detected at the telomeric and ALU repeats in all conditions tested, excluding the possibility that colcemid treatment changes the accessibility of chromatin to antibodies (Fig. 5a,b) . TRF2 binding to telomeric repeats was reduced by approximately 50% at the 30-h time point (Fig. 5a,b , 5′-TTAGGG-3′). Conversely, forced retroviral expression of TRF2 (Fig. 5c) led to a reduction of meta-TIF to almost background levels in asynchronous and synchronized cells (Fig. 5d) , while leaving the efficiency of mitotic arrest unchanged (not shown), emphasizing the central role that TRF2 has in suppressing meta-TIF formation. TRF1 levels at telomeric repeats were also slightly reduced during mitotic arrest (Fig. 5b) . However, we do not suspect a role for TRF1 in this phenotype, as TRF1 overexpression did not substantially rescue the TIF phenotype (not shown), which is consistent with the lack of a major role for TRF1 in telomere protection 27 . We also examined whole-cell extracts of IMR90 cells exposed to colcemid up to 36 h and found no evidence for downregulation of shelterin components at the protein level (Supplementary Fig. 6a ). We suggest that TRF2 is partially removed from telomeres during prolonged mitotic arrest, probably owing to post-translational regulation and not simply by protein degradation.
Prolonged mitotic arrest dissociates TRF2 from telomeres
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p53-dependent G1 arrest of cells with meta-TIF
Cells suffering from ionizing radiation-induced DNA damage in mitosis activate the checkpoint response in the following G1 phase 28 . To examine whether meta-TIF induced by mitotic arrest persist into G1 after release, mitotic IMR-90 cells were collected by shake-off, replated and cultured. TIF were evident in arrested mitotic cells and in the rounded cells and recently divided cells 2-6 h after shake-off.
TIF became less evident 8 h post shake-off and were almost gone by 10 h (Fig. 6a) . This suggests that TIF persist into early G1 phase before eventual repair. As a control, mitotic cells fixed 10 h after release from the double-thymidine block without colcemid treatment show no meta-TIF phenotype.
To address checkpoint activation in the following cell cycle, we monitored p53 and p21 in IMR90 cells at the 24-and 48-h time points post release from a prolonged mitotic arrest (Fig. 6b) . Cells shaken off at the 10-h time point showed a slight increase in p53 and p21 levels after a 24-h recovery period, which diminished after 48 h (Fig. 6c) . By contrast, when mitotic cells were collected at the 16-h time point, activation of p53 (p53-Ser15P) and a strong p53 and p21 accumulation could be detected at up to 48 h (Fig. 6c) . This suggests that prolonged mitotic arrest caused a p53-dependent cell-cycle arrest in the following G1 phase.
To examine whether cells are indeed arrested in the following G1 phase in a p53-dependent manner, presynchronized IMR90 and IMR90 E6E7 cells were collected by mitotic shake-off after colcemid treatment and grown for 20 h followed by a 4-h BrdU-incorporation interval (Fig. 6d) . Both cell types accumulated TIF during prolonged mitotic arrest, confirming that p53-negative IMR90 cells were still competent for meta-TIF formation (Supplementary Fig. 5b ). Both populations released at the 10-h time point efficiently incorporated BrdU after a 20-h recovery period, indicating that they entered the next round of the cell cycle (Fig. 6e, middle) . When cells were released at the 16-h time point, IMR90 cells did not incorporate BrdU, whereas IMR90 E6E7 cells incorporated BrdU but showed an increasing population of BrdU-positive cells with polyploid DNA content (Fig. 6e,  right) . The diploid DNA content of the IMR90 cells released at the 10-and 16-h time points suggests that they progressed through cytokinesis (Supplementary Fig. 5c ), which argues against the possibility that tetraploidy is required for the cell-cycle arrest that follows 29 . Our results support the hypothesis that in the presence of a functional p53 pathway, cells with extensive meta-TIF succumb to a growth arrest in the following G1 phase of the cell cycle. By contrast, when the p53 pathway is compromised, the cells continue progression through the cell cycle and become aneuploid.
To examine whether mitotic telomere deprotection causes telomere fusions in either the same mitosis or the following cell cycle, presynchronized IMR90 E6E7 cells were treated with colcemid, shaken off at the 10-and 24-h time points and monitored for telomeric fusions after a 24-and 48-h recovery period. No increase of telomeric fusions during and after prolonged mitotic arrest was noted (Supplementary Fig. 5d ). This indicates that telomere deprotection does not cause telomeric fusion during mitosis and the following cellcycle phase, which is consistent with the finding that partial TRF2 loss allows telomeres to be recognized as damage without resulting in chromosome fusions 8 . The lack of fusions in a scenario that shows overhang loss is inconsistent with the suggestion that nonhomologous end joining (NHEJ)-dependent chromosome ligation is required for removal of the telomeric overhangs 30 . We suggest that the incomplete removal of TRF2 from telomeres during mitotic arrest, compounded with the absence of NHEJ activity during mitosis and the subsequent reestablishment of protection in the following G1 phase after release from mitotic arrest account for the differences in findings.
The Meta-TIF phenotype depends on Aurora B kinase activity The phases of mitosis are monitored by the SAC, which prevents anaphase onset by targeting the APC, when the chromosomes fail to attach to spindle microtubules 31 . Aurora B kinase is critical in the correction of the microtubule mal-attachments and is involved in SAC signaling 31, 32 . To test whether the SAC pathway is involved in mitotic telomere deprotection we targeted Aurora B by hesperadin in the presence of Velcade. Velcade inhibits proteolysis of APC substrates, thereby canceling the requirement for SAC-dependent mitotic arrest. Staining with the mitotic protein monoclonal no. 2 (MPM-2) showed that hesperadin strongly inhibited mitotic arrest induced by Taxol, verifying SAC inactivation (Fig. 7a,b) . In Velcade-treated cells, hesperadin prevented H3S10P from forming as a consequence of Aurora B inhibition, and Aurora A inhibitor I, used as a control, prevented Aurora A autophosphorylation, emphasizing the specificity of these inhibitors (Supplementary Fig. 6c ). In this setting, hesperadin, but not Aurora A Inhibitor I, prevented the accumulation of meta-TIF (Fig. 7c,d) , suggesting that mitotic telomere deprotection is dependent on Aurora B kinase activity. Aurora B-inhibited cells were still competent for DNA damage signaling upon 1 Gy irradiation, excluding the possibility that hesperadin inhibits ATM activity (Supplementary Fig. 6d,e) . We were not able to test whether continuous Aurora B inhibition after washing out Velcade had an effect on telomeric TRF2 or on the telomere-protection status, as these experimental conditions led to anaphase and cytokinesis failure, comparable to what occurs in a prolonged Aurora B knockdown 33 .
To distinguish between a role of Aurora B or the SAC in meta-TIF formation we exposed Velcade-treated cells to reversine, which inhibits MPS1 (MonoPolar Spindle 1) and therefore the SAC 34 , but does not alter Aurora A or B activity at the concentrations used ( Supplementary Fig. 6b,d) . Reversine-dependent MPS1 suppression inhibited mitotic arrest induced by Taxol, as expected (Fig. 7b) , but failed to suppress telomeric-damage foci formation in Velcadetreated cells (Fig. 7c,d) , which indicates that Aurora B, but not the SAC pathway, is involved in the meta-TIF induction. These results indicate that telomere deprotection after prolonged mitotic arrest is a programmed response ensuring DNA damage checkpoint activation and cell growth arrest. npg a r t i c l e s DISCUSSION Here we describe a checkpoint pathway that is triggered following prolonged mitotic arrest. We propose a model in which prolonged mitotic duration results in destabilization of the telomere binding protein TRF2, causing telomere dysfunction and activation of a DNA damage response at chromosome ends. When activated in primary cells, this checkpoint leads to cell-cycle arrest and apoptosis in the following G1 phase of the cell cycle (Fig. 8) . If activated in transformed cells, this checkpoint could send transformed cells on a path to aneuploidy. Previous observations reported that mitotic arrest is associated with the formation of chromosomal γ-H2AX foci, but the cause of this DNA damage response was obscure 35, 36 . We propose a model in which partial loss of TRF2 during mitotic arrest triggers an ATM-dependent damage response and degradation of the telomeric G-strand overhang. Our model shows a simple and effective mechanism to induce the DNA damage response pathway that results in the exposure of telomeric ends to the DNA damage checkpoint machinery. It remains unclear how TRF2, or potentially other shelterin components, are specifically removed from telomeres; however, we suspect an active process, involving mitosis-specific post-translational modifications of TRF2. It is possible that factors such as phosphatases, which inhibit putative modification of TRF2, antagonize Aurora B kinase-dependent telomere deprotection and gradually degrade during prolonged mitotic arrest, controlling the time dependence of TRF2 removal from telomeres. It is also possible that Aurora B activity at telomeres increases as a function of time spent in mitosis, and when a threshold is exceeded, TRF2 gets modified and removed.
Mitotic inhibitors are frequently used during treatment of a wide variety of cancers, and mitosis progression has long been viewed as an attractive target for the development of new therapeutic candidates 37 . Although the mechanism for the induction of cell death upon mitotic inhibition is not understood, it has been proposed that the p53-dependent checkpoint upon spindle disruption overlaps with the p53-dependent checkpoint following DNA damage 38 . Here we propose that telomere deprotection is the universal signal that initiates the DNA damage response upon failure to complete mitosis.
Our finding that cells with a competent p53 pathway become arrested in G1 after release or escape from mitotic arrest, whereas cells lacking functional p53 and Rb pathways continue to cycle in the presence of DNA damage signaling offers an explanation of why transformed cells are more sensitive to mitotic inhibitors than primary cells. However, the finding that telomere deprotection is the initiating signal for the damage response upon mitotic inhibition also suggests caution in the use of such drugs, as cells that escape the mitotic block will inevitably suffer from telomere deprotection and are prone to become aneuploid. On the other hand, it could be beneficial to combine mitotic inhibitors with drugs that sensitize cells to active damage signaling. Furthermore, considering that a loss of the 3′ overhang is the initiating signal for the damage response, it might be effective to combine mitotic inhibitors with telomerase inhibitors, as telomerase has the capability to regenerate a 3′ overhang at chromosome ends.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/.
